603567.SS
603567.SS
CNE100002219
HEILONGJIANG ZBD PHARMACEUTICAL
Loading chart...

Company Profile

Heilongjiang ZBD Pharmaceutical Co., Ltd. engages in the pharmaceuticals business in China. The company researches, develops, produces, and sale traditional Chinese medicine preparations, biological agents, and chemical agents, as well as involved in the pharmaceutical and Chinese medicinal materials trade; and leasing business. It also engages in pharmaceutical manufacturing; contract manufacturing of pharmaceuticals; pharmaceutical retail and wholesale; testing and inspection services; pharmaceutical internet information services; laboratory animal production; and laboratory animal management. The company offers medicines in the field of cardiovascular and cerebrovascular, anti-infectives, respiratory system drugs, tumors, and antiviral drugs diseases. Heilongjiang ZBD Pharmaceutical Co., Ltd. was founded in 1996 and is based in Harbin, China.

Related stocks

002793.SZ
002793.SZ • China
LUOXINPHARMACEUTICAL
4.89 CNY
795.8M USD 1Y -0.2%
9989.HK
9989.HK • China
HEPALINK
4.03 HKD
752.61M USD 1Y -26.6%
300194.SZ
300194.SZ • China
FUAN PHARM
4.03 CNY
717.42M USD 1Y -7.8%
300039.SZ
300039.SZ • China
SHANGHAI KAIBAO
5.39 CNY
843.62M USD 1Y -11.8%
300485.SZ
300485.SZ • China
SCIENCE SUN
8.57 CNY
617.67M USD 1Y -24%
002737.SZ
002737.SZ • China
SFPM
11.53 CNY
1.01B USD 1Y -24.8%
600351.SS
600351.SS • China
YABAO PHARMACEUTICAL GROUP CO L
7.07 CNY
732.07M USD 1Y +6.8%
600829.SS
600829.SS • China
HPGC RENMINTONGTAI PHARMACEUTIC
9.52 CNY
826.06M USD 1Y +19.9%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
39.7% p.a.
Max Drawdown (5Y)
-76.2%
Sharpe Ratio (5Y)
-0.60
Beta Factor
0.22
Size Class
Mid Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (39.7% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -81.5% in the extended horizon.
ende